{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:11:33Z","timestamp":1792300293457,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T00:00:00Z","timestamp":1422230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T00:00:00Z","timestamp":1422230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.1038\/onc.2014.443","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T11:40:15Z","timestamp":1422272415000},"page":"5198-5205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk"],"prefix":"10.1038","volume":"34","author":[{"given":"N","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,26]]},"reference":[{"key":"BFonc2014443_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10549-004-2172-4","volume":"89","author":"M Lacroix","year":"2005","unstructured":"Lacroix M, Leclercq G . The \"portrait\" of hereditary breast cancer. Breast Cancer Res Treat 2005; 89: 297\u2013304.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014443_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King MC . Ten genes for inherited breast cancer. Cancer Cell 2007; 11: 103\u2013105.","journal-title":"Cancer Cell"},{"key":"BFonc2014443_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ng.569","volume":"42","author":"A Meindl","year":"2010","unstructured":"Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 2010; 42: 410\u2013414.","journal-title":"Nat Genet"},{"key":"BFonc2014443_CR4","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/ijc.28540","volume":"134","author":"S Guti\u00e9rrez-Enr\u00edquez","year":"2014","unstructured":"Guti\u00e9rrez-Enr\u00edquez S, Bonache S, de Garibay GR, Osorio A, Santamari\u00f1a M, Ram\u00f3n y Cajal T et al. About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants. Int J Cancer 2014; 134: 2088\u20132097.","journal-title":"Int J Cancer"},{"key":"BFonc2014443_CR5","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1093\/hmg\/dds115","volume":"21","author":"A Osorio","year":"2012","unstructured":"Osorio A, Endt D, Fern\u00e1ndez F, Eirich K, de la Hoya M, Schmutzler R et al. Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families. Hum Mol Genet 2012; 21: 2889\u20132898.","journal-title":"Hum Mol Genet"},{"key":"BFonc2014443_CR6","doi-asserted-by":"publisher","first-page":"747318","DOI":"10.1155\/2013\/747318","volume":"2013","author":"P Apostolou","year":"2013","unstructured":"Apostolou P, Fostira F . Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int 2013; 2013: 747318.","journal-title":"Biomed Res Int"},{"key":"BFonc2014443_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB . Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643\u2013646.","journal-title":"Science"},{"key":"BFonc2014443_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/humu.10154","volume":"20","author":"A Liede","year":"2002","unstructured":"Liede A, Narod SA . Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 2002; 20: 413\u2013424.","journal-title":"Hum Mutat"},{"key":"BFonc2014443_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","volume":"26","author":"M Weischer","year":"2008","unstructured":"Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG . CHEK2- 1100delC genotyping for clinical assessment of breast cancer risk: metaanalyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 2008; 26: 542\u2013548.","journal-title":"J Clin Oncol"},{"key":"BFonc2014443_CR10","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.7314\/APJCP.2012.13.4.1355","volume":"13","author":"C Liu","year":"2012","unstructured":"Liu C, Wang Y, Wang QS, Wang YJ . The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2012; 13: 1355\u20131360.","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFonc2014443_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nrc2251","volume":"7","author":"L Antoni","year":"2007","unstructured":"Antoni L, Sodha N, Collins I, Garrett MD . CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? Nat Rev Cancer 2007; 7: 925\u2013936.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014443_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s12325-008-0057-3","volume":"25","author":"W Chen","year":"2008","unstructured":"Chen W, Yurong S, Liansheng N . Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: not present in the Chinese familial breast cancer population. Adv Ther 2008; 25: 496\u2013501.","journal-title":"Adv Ther"},{"key":"BFonc2014443_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10549-007-9743-0","volume":"110","author":"P Gonz\u00e1lez-Hormaz\u00e1bal","year":"2008","unstructured":"Gonz\u00e1lez-Hormaz\u00e1bal P, Castro VG, Blanco R, G\u00f3mez F, Peralta O, Waugh E et al. Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population. Breast Cancer Res Treat 2008; 110: 543\u2013545.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014443_CR14","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.7314\/APJCP.2014.15.22.10021","volume":"15","author":"Q-K Song","year":"2014","unstructured":"Song Q-K, Li J, Huang R, Fan J-H, Zheng R-S, Zhang B-N et al. Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European union. Asian Pac J Cancer Prev 2014; 15: 10021\u201310025.","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFonc2014443_CR15","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1007\/s00268-008-9589-6","volume":"32","author":"A Kwong","year":"2008","unstructured":"Kwong A, Cheung P, Chan S, Lau S . Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg 2008; 32: 2554\u20132561.","journal-title":"World J Surg"},{"key":"BFonc2014443_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1086\/341943","volume":"71","author":"P Vahteristo","year":"2002","unstructured":"Vahteristo P, Bartkova J, Eerola H, Syrj\u00e4koski K, Ojala S, Kilpivaara O et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71: 432\u2013438.","journal-title":"Am J Hum Genet"},{"key":"BFonc2014443_CR17","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1073\/pnas.96.7.3745","volume":"96","author":"AL Brown","year":"1999","unstructured":"Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H, Chung JH . A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc Natl Acad Sci USA 1999; 96: 3745\u20133750.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014443_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/35103059","volume":"2","author":"J Bartek","year":"2001","unstructured":"Bartek J, Falck J, Lukas J . CHK2 kinase-a busy messenger. Nat Rev Mol Cell Biol 2001; 2: 877\u2013886.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014443_CR19","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gad.1815309","volume":"23","author":"H Jiang","year":"2009","unstructured":"Jiang H, Reinhardt HC, Bartkova J, Tommiska J, Blomqvist C, Nevanlinna H et al. The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev 2009; 23: 1895\u20131909.","journal-title":"Genes Dev"},{"key":"BFonc2014443_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nchembio.503","volume":"7","author":"H Jiang","year":"2011","unstructured":"Jiang H, Pritchard JR, Williams RT, Lauffenburger DA, Hemann MT . A mammalian functional-genetic approach to characterizing cancer therapeutics. Nat Chem Biol 2011; 7: 92\u2013100.","journal-title":"Nat Chem Biol"},{"key":"BFonc2014443_CR21","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s11033-013-2956-x","volume":"41","author":"AH Baloch","year":"2014","unstructured":"Baloch AH, Daud S, Raheem N, Luqman M, Ahmad A, Rehman A et al. Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin. Mol Biol Rep 2014; 41: 1103\u20131107.","journal-title":"Mol Biol Rep"},{"key":"BFonc2014443_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg1746","volume":"7","author":"M O'Driscoll","year":"2006","unstructured":"O'Driscoll M, Jeggo PA . The role of double-strand break repair - insights from human genetics. Nat Rev Genet 2006; 7: 45\u201354.","journal-title":"Nat Rev Genet"},{"key":"BFonc2014443_CR23","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski C, Woko\u0142orczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J et al. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 2011; 29: 3747\u20133752.","journal-title":"J Clin Oncol"},{"key":"BFonc2014443_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1101\/gad.14.3.289","volume":"14","author":"SY Shieh","year":"2000","unstructured":"Shieh SY, Ahn J, Tamai K, Taya Y, Prives C . The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage inducible sites. Genes Dev 2000; 14: 289\u2013300.","journal-title":"Genes Dev"},{"key":"BFonc2014443_CR25","doi-asserted-by":"publisher","first-page":"13777","DOI":"10.1073\/pnas.96.24.13777","volume":"96","author":"SY Shieh","year":"1999","unstructured":"Shieh SY, Ahn J, Tamai K, Taya Y, Prives C . Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 1999; 96: 13777\u201313782.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014443_CR26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.14.3.278","volume":"14","author":"NH Chehab","year":"2000","unstructured":"Chehab NH, Malikzay A, Appel M, Halazonetis TD . Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 2000; 14: 278\u2013288.","journal-title":"Genes Dev"},{"key":"BFonc2014443_CR27","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","volume":"17","author":"FJ Stott","year":"1998","unstructured":"Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S et al. The alternative product from the human CDKN2A locus, p14 (ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998; 17: 5001\u20135014.","journal-title":"EMBO J"},{"key":"BFonc2014443_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ . Surfing the p53 network. Nature 2000; 408: 307\u2013310.","journal-title":"Nature"},{"key":"BFonc2014443_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0955-0674(00)00216-7","volume":"13","author":"KM Ryan","year":"2001","unstructured":"Ryan KM, Phillips AC, Vousden KH . Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001; 13: 332\u2013337.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2014443_CR30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.molcel.2009.09.007","volume":"35","author":"Z Cai","year":"2009","unstructured":"Cai Z, Chehab NH, Pavletich NP . Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase. Mol Cell 2009; 35: 818\u2013829.","journal-title":"Mol Cell"},{"key":"BFonc2014443_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.dnarep.2004.03.033","volume":"3","author":"J Ahn","year":"2004","unstructured":"Ahn J, Urist M, Prives C . The Chk2 protein kinase. DNA Repair (Amst) 2004; 3: 1039\u20131047.","journal-title":"DNA Repair (Amst)"},{"key":"BFonc2014443_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J Bartek","year":"2003","unstructured":"Bartek J, Lukas J . Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003; 3: 421\u2013429.","journal-title":"Cancer Cell"},{"key":"BFonc2014443_CR33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.dnarep.2009.04.012","volume":"8","author":"TH Stracker","year":"2009","unstructured":"Stracker TH, Usui T, Petrini JH . Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst) 2009; 8: 1047\u20131054.","journal-title":"DNA Repair (Amst)"},{"key":"BFonc2014443_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ccr.2012.01.021","volume":"21","author":"S Takacova","year":"2012","unstructured":"Takacova S, Slany R, Bartkova J, Stranecky V, Dolezel P, Luzna P et al. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo. Cancer Cell 2012; 21: 517\u2013531.","journal-title":"Cancer Cell"},{"key":"BFonc2014443_CR35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova J, Horejs\u00ed Z, Koed K, Kr\u00e4mer A, Tort F, Zieger K et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864\u2013870.","journal-title":"Nature"},{"key":"BFonc2014443_CR36","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1084\/jem.20122842","volume":"210","author":"NF de Miranda","year":"2013","unstructured":"de Miranda NF, Peng R, Georgiou K, Wu C, Falk S\u00f6rqvist E, Berglund M et al. DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J Exp Med 2013; 210: 1729\u20131742.","journal-title":"J Exp Med"},{"key":"BFonc2014443_CR37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1086\/421251","volume":"74","author":"Consortium CBCC","year":"2004","unstructured":"Consortium CBCC. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004; 74: 1175\u20131182.","journal-title":"Am J Hum Genet"},{"key":"BFonc2014443_CR38","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1074\/jbc.M009727200","volume":"276","author":"X Wu","year":"2001","unstructured":"Wu X, Webster SR, Chen J . Characterization of tumor-associated Chk2 mutations. J Biol Chem 2001; 276: 2971\u20132974.","journal-title":"J Biol Chem"},{"key":"BFonc2014443_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1471-2407-8-239","volume":"8","author":"DJ Novak","year":"2008","unstructured":"Novak DJ, Chen LQ, Ghadirian P, Hamel N, Zhang P, Rossiny V et al. Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women. BMC Cancer 2008; 8: 239.","journal-title":"BMC Cancer"},{"key":"BFonc2014443_CR40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1399-0004.2006.00711.x","volume":"70","author":"H Brinkman","year":"2006","unstructured":"Brinkman H, Barwell J, Rose S, Tinworth L, Sodha N, Langman C et al. Evidence against a major genetic basis for combined breast and colorectal cancer susceptibility. Clin Genet 2006; 70: 526\u2013529.","journal-title":"Clin Genet"},{"key":"BFonc2014443_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10549-009-0598-4","volume":"120","author":"AY Cao","year":"2010","unstructured":"Cao AY, Hu Z, Shao ZM . Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China. Breast Cancer Res Treat 2010; 120: 271\u2013272.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014443_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ygyno.2004.07.015","volume":"95","author":"BE Baysal","year":"2004","unstructured":"Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F et al. Analysis of CHEK2 gene for ovarian cancer susceptibility. Gynecol Oncol 2004; 95: 62\u201369.","journal-title":"Gynecol Oncol"},{"key":"BFonc2014443_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/humu.10031","volume":"19","author":"N Sodha","year":"2002","unstructured":"Sodha N, Houlston RS, Williams R, Yuille MA, Mangion J, Eeles RA . A robust method for detecting CHK2\/RAD53 mutations in genomic DNA. Hum Mutat 2002; 19: 173\u2013177.","journal-title":"Hum Mutat"},{"key":"BFonc2014443_CR44","first-page":"5718","volume":"61","author":"P Vahteristo","year":"2001","unstructured":"Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA et al. P53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res 2001; 61: 5718\u20135722.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014443","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:40:20Z","timestamp":1647895220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,26]]},"references-count":44,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2015,10,1]]}},"alternative-id":["BFonc2014443"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.443","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,26]]},"assertion":[{"value":"17 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}